Skip to content
HowShorted

GENOCEA BIOSCIENCES, INC. short interest in 2018

In 2018, GENOCEA BIOSCIENCES, INC.'s disclosed short interest ran from 5.75% of shares outstanding on 12 Jan 2018 to 2.30% on 31 Dec 2018, a change of -3.45 percentage points. The year's high was 20.15% on 30 Apr 2018 and its low 1.52% on 15 Aug 2018, averaging 6.28% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.08 days on 30 Nov 2018. Full history: GENOCEA BIOSCIENCES, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for GENOCEA BIOSCIENCES, INC. in 2018

2018 in figures

Start of year
5.75% (12 Jan 2018)
End of year
2.30% (31 Dec 2018)
Change
-3.45 pp
High
20.15% (30 Apr 2018)
Low
1.52% (15 Aug 2018)
Average
6.28%
Highest days to cover
15.08 (30 Nov 2018)
SEC filings marked
9

Every report in 2018

GENOCEA BIOSCIENCES, INC. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 20185.75%2.92
31 Jan 201810.00%1.50results (8-K)
15 Feb 20188.54%2.22results (8-K)
28 Feb 20184.62%1.8210-K filed
15 Mar 20187.68%1.35
29 Mar 201813.28%3.45
13 Apr 201816.74%5.89
30 Apr 201820.15%6.46
15 May 20186.71%10.93results (8-K), 10-Q filed
31 May 20185.17%10.24
15 Jun 20187.10%10.48
15 Aug 20181.52%3.83results (8-K), 10-Q filed
31 Aug 20182.09%4.95
14 Sep 20182.79%8.02
28 Sep 20183.12%3.48
15 Oct 20183.27%8.05
31 Oct 20183.16%14.54
15 Nov 20182.85%8.7310-Q filed, results (8-K)
30 Nov 20182.58%15.08
14 Dec 20182.54%14.02
31 Dec 20182.30%3.82

See also: GENOCEA BIOSCIENCES, INC.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.